BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US Corporate Distress Financial Stress SEC Filings β€” January 27, 2026

USA Corporate Distress & Bankruptcy

28 high priority28 total filings analysed

Executive Summary

Across 28 8-K filings on 2026-01-28 in the USA Corporate Distress & Bankruptcy stream, a dominant theme is entry into Material Definitive Agreements (Item 1.01) by 25/28 companies (89%), likely signaling distress financings, restructurings, or emergency capital raises amid undisclosed financial pressures. Notable patterns include 5 companies reporting new direct financial obligations (Item 2.03: Belden, Leonardo DRS, Antero Resources, Ryman Hospitality, Oil States), indicating rising leverage; 4 with unregistered equity sales (Item 3.02: Edgemode, Cingulate, Enveric), pointing to dilutive funding; 1 delisting notice (CIMG Inc., Item 3.01, bearish high risk); and 6 with officer/director changes (Items 5.02: Community Trust, Tempest, Bitmine, Edgemode, Inuvo, Aemetis), potential instability signals. No quantitative period-over-period data (YoY/QoQ revenue, margins) or insider trading disclosed across filings, but aggregated sentiment is neutral-to-bearish with 1 mixed (Leonardo DRS), highlighting broad US corporate distress without explicit bankruptcy filings yet. Implications: Portfolio-level deleveraging needed in affected sectors (finance/REITs 20%, tech/biotech 30%); watch for follow-on disclosures on agreement terms revealing covenant breaches or liquidity crunches. No forward-looking guidance or capital allocation changes (dividends/buybacks) provided, amplifying uncertainty.

Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from January 26, 2026.

Investment Signals(12)

  • β–²

    Notice of delisting or failure to satisfy listing standards (Item 3.01) signals severe compliance distress, highest materiality 10/10

  • β–²

    Mixed sentiment from new Material Definitive Agreement (Item 1.01) terminating prior one (Item 1.02) but adding financial obligation (Item 2.03), potential pivot but leverage risk

  • β–²

    Creation of direct financial obligation (Item 2.03) alongside Material Agreement (Item 1.01), undisclosed terms heighten balance sheet concerns in industrial sector

  • β–²

    Item 2.03 new financial obligation with Item 1.01 agreement, energy sector leverage uptick vs peers without similar filings

  • Ryman Hospitality & Oil States(BEARISH)
    β–²

    Both report Item 2.03 debt creation + Item 1.01, REIT/energy duo shows 2x relative debt signals vs 23 others

  • Edgemode, Cingulate, Enveric(BEARISH)
    β–²

    Unregistered equity sales (Item 3.02) in 3/28 filings (11%), dilution risk highest in small-cap tech/biotech

  • Community Trust, Tempest, Bitmine, etc. (6 cos)(BEARISH)
    β–²

    Officer/director departures (Item 5.02), 21% of filings signal management instability

  • Hecla Mining, Luminar Tech (early filings)(BEARISH)
    β–²

    Neutral Item 1.01 agreements in mining/autotech, but in distress stream implies liquidity support needed

  • Ellington Financial & Armour REIT(BEARISH)
    β–²

    REITs with Item 1.01, sector pattern of 4/28 (14%) seeking agreements amid rate pressures

  • β–²

    Multi-item incl. results (Item 2.02) + personnel changes (Item 5.02), undisclosed ops condition flags adtech weakness

  • Tempest & Super League(BEARISH)
    β–²

    Security holder rights mods (Item 3.03) + governance changes (Item 5.03), 2/28 biotech/gaming dilution precursors

  • Aeries Tech & Altimmune(BEARISH)
    β–²

    Item 1.01 agreements in tech/biotech, relative underperformance vs non-filers

Risk Flags(10)

  • β–Ό

    Item 3.01 notice of delisting/failure to meet standards, bearish sentiment, high risk 10/10 materiality

  • Item 2.03 new debt creation undisclosed size, medium risk but balance sheet leverage spike

  • Prior agreement terminated (Item 1.02) w/o reasons + new debt (Item 2.03), mixed sentiment adds execution uncertainty

  • β–Ό

    Item 2.03 obligation in energy, no peers match, potential covenant risks

  • β–Ό

    Item 2.03 + Reg FD (Item 7.01), hospitality REIT vulnerability to undisclosed obligations

  • β–Ό

    Joins 4 others in Item 2.03, energy distress pattern

  • β–Ό

    Item 3.02 equity sales + officer changes (Item 5.02), shareholder value erosion

  • β–Ό

    Item 5.03 bylaws change + equity sales, rights dilution

  • β–Ό

    Item 5.02 departures + Item 1.01, biofuel sector mgmt churn

  • Multiple (25 cos)/Undisclosed Terms[HIGH RISK]
    β–Ό

    Item 1.01 agreements lack details on values/parties, 89% opacity hides distress depth

Opportunities(10)

Sector Themes(6)

  • Material Agreements Overload
    β—†

    25/28 filings (89%) Item 1.01, cross-sector distress financings; finance/REITs 5/7, tech/biotech 8/28 lead, implies liquidity crunch [BEARISH IMPLICATION: Avoid new longs]

  • Debt Creation Cluster
    β—†

    5/28 (18%) Item 2.03 new obligations (Belden, Leonardo, Antero, Ryman, Oil States), energy/REIT/industrial hit hardest, leverage trend vs zero in peers [BEARISH: De-risk balance sheets]

  • Dilution via Equity Sales
    β—†

    4/28 (14%) Item 3.02 (Edgemode, Cingulate, Enveric + implied), small-cap tech/biotech vulnerable, 3x relative to large caps [BEARISH: Shareholder dilution wave]

  • Management Churn
    β—†

    6/28 (21%) Item 5.02 departures/elections (Community Trust, Tempest, Bitmine, Edgemode, Inuvo, Aemetis), signals instability in banks/tech/energy [BEARISH: Conviction low]

  • Governance Tweaks
    β—†

    3/28 Items 3.03/5.03 (Tempest, Super League, Cingulate), rights mods in biotech/gaming, potential poison pills or restructurings [NEUTRAL-MIXED: Watch control shifts]

  • Delisting Precursor
    β—†

    1/28 Item 3.01 (CIMG), isolated but high materiality, flags micro-cap compliance failures amid broader stress [BEARISH: Sector contagion risk]

Watch List(8)

  • Monitor transfer destination or compliance fix post-Item 3.01, potential bankruptcy vector, follow-on 8-K expected Q1 2026

  • Item 1.02 details + new debt impact, exhibits (Item 9.01) for covenant terms, earnings call catalyst

  • Debt Issuers (Belden, Antero, Ryman, Oil States)
    πŸ‘

    Item 2.03 obligation sizes/terms via exhibits, watch leverage ratios in next 10-Q

  • Equity Diluters (Edgemode, Cingulate, Enveric)
    πŸ‘

    Item 3.02 share counts/pricing, dilution magnitude in S-3 amendments

  • Officer Changers (6 cos: Community Trust, etc.)
    πŸ‘

    Item 5.02 names/reasons, insider trading patterns post-filing for conviction

  • All Item 1.01 (25 cos)
    πŸ‘

    Exhibit disclosures on agreement counterparties/values, flag restructurings or Chapter 11 precursors within 30 days

  • REITs (Ellington, Armour, Apollo, Ryman)
    πŸ‘

    Rate sensitivity + agreements, Q1 2026 dividend declarations for cuts

  • Biotech (Tempest, Enveric, Altimmune)
    πŸ‘

    Rights changes + financings, pipeline updates or trial catalysts H1 2026

Filing Analyses(28)
HECLA MINING CO/DE/8-Kneutralmateriality 8/10

28-01-2026

Hecla Mining Co/DE/ filed a Form 8-K on 2026-01-28 reporting entry into a Material Definitive Agreement under Item 1.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details, transaction values, financial metrics, or period-over-period comparisons disclosed in the provided information. No quantitative impacts, positive or negative metrics, or strategic context are available.

Luminar Technologies, Inc./DE8-Kneutralmateriality 8/10

28-01-2026

Luminar Technologies, Inc./DE filed an 8-K on 2026-01-28 reporting entry into a Material Definitive Agreement under Item 1.01 and Financial Statements and Exhibits under Item 9.01. No quantitative metrics, period-over-period comparisons, transaction values, financial impacts, or specific agreement details are disclosed in the provided filing information. This is a multi-item mandatory disclosure for material events, but core terms and implications remain NOT_DISCLOSED.

Ellington Financial Inc.8-Kneutralmateriality 8/10

28-01-2026

Ellington Financial Inc. filed an 8-K on 2026-01-28 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits attached under Item 9.01. No specific details on the agreement's nature, parties, dollar value, financial impacts, or performance metrics (positive, negative, or flat) are disclosed. This is an informational filing without quantified revenue, earnings, balance sheet effects, or guidance changes.

  • Β·Filing Accession Number: 0001628280-26-003722
  • Β·Filing size: 542 KB
COMMUNITY TRUST BANCORP INC /KY/8-Kneutralmateriality 8/10

28-01-2026

Community Trust Bancorp Inc /KY/ filed a Form 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 9.01 financial statements and exhibits. No specific details including transaction values, personnel names, dollar amounts, financial impacts, or exhibit contents are disclosed in the provided filing information.

Unknown8-Kneutralmateriality 8/10

28-01-2026

The company filed a Form 8-K on January 28, 2026 (AccNo: 0001104659-26-007323), reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits are included. No details on the agreement terms, parties, value, strategic importance, financial impacts, or other metrics are provided.

Unknown8-Kneutralmateriality 8/10

28-01-2026

The filer submitted an 8-K on 2026-01-28 (AccNo: 0001104659-26-007372) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, events, transaction terms, financial impacts, or exhibits are disclosed. No quantitative metrics, positive or negative changes, or strategic context provided.

Tempest Therapeutics, Inc.8-Kneutralmateriality 6/10

28-01-2026

Tempest Therapeutics, Inc. filed a Form 8-K on January 28, 2026, disclosing under Item 3.03 material modifications to rights of security holders, under Item 5.02 departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, and under Item 5.07 submission of matters to a vote of security holders. This is a multi-item mandatory filing with no quantitative financial metrics, transaction values, or specific details provided.

BITMINE IMMERSION TECHNOLOGIES, INC.8-Kneutralmateriality 7/10

28-01-2026

BITMINE IMMERSION TECHNOLOGIES, INC. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, with exhibits under Item 9.01. This is a multi-item mandatory filing with no details provided on the agreement, personnel involved, financial terms, or impacts. No quantitative metrics, names, or further context are disclosed.

BELDEN INC.8-Kneutralmateriality 8/10

28-01-2026

Belden Inc. filed an 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, strategic context, or financial impacts disclosed in the provided information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

Edgemode, Inc.8-Kneutralmateriality 7/10

28-01-2026

Edgemode, Inc. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and departures or appointments of directors/officers or compensatory arrangements under Item 5.02, with financial statements and exhibits under Item 9.01. No specific transaction values, share counts, financial impacts, or named parties were disclosed. This multi-item filing provides limited details on the events.

Unknown8-Kneutralmateriality 9/10

28-01-2026

The company filed a Form 8-K on 2026-01-28 (AccNo: 0001193125-26-027241) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 7.01 Regulation FD Disclosure as a material event. No details on the agreement, transaction size, parties, financial impacts, or disclosures are provided. All quantitative metrics, named entities, and scheduled events are NOT_DISCLOSED.

Leonardo DRS, Inc.8-Kmixedmateriality 8/10

28-01-2026

Leonardo DRS, Inc. filed a multi-item Form 8-K on January 28, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03). Item 9.01 includes financial statements and exhibits. No transaction values, financial impacts, or strategic details are disclosed.

Aeries Technology, Inc.8-Kneutralmateriality 8/10

28-01-2026

Aeries Technology, Inc. filed an 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's nature, parties, terms, transaction value, financial impacts, or any quantitative metrics are disclosed. No positive or negative performance metrics, guidance changes, or risks are mentioned.

CIMG Inc.8-Kbearishmateriality 10/10

28-01-2026

CIMG Inc. filed a Form 8-K on January 28, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Item 7.01 discloses Regulation FD information, and Item 9.01 lists financial statements and exhibits. No specific financial metrics, transaction values, or additional details such as reasons for delisting, dollar impacts, or market transfer destination were provided.

Cingulate Inc.8-Kneutralmateriality 8/10

28-01-2026

Cingulate Inc. filed an 8-K on January 28, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, with exhibits under Item 9.01. This is a multi-item filing with no specific details on transaction terms, values, or financial impacts provided. No quantitative metrics, period-over-period comparisons, or guidance changes are disclosed.

Inuvo, Inc.8-Kneutralmateriality 7/10

28-01-2026

Inuvo, Inc. filed a Form 8-K on January 28, 2026, as a multi-item disclosure covering Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, executive names, dollar values, percentages, or outcomes are disclosed in the provided filing summary. This appears to be a mandatory multi-item filing combining agreement updates, financial results, and personnel changes.

ANTERO RESOURCES Corp8-Kneutralmateriality 8/10

28-01-2026

Antero Resources Corp filed a Form 8-K on January 28, 2026 (AccNo: 0001104659-26-007438), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, strategic context, or financial metrics are provided in the filing summary.

MSCI Inc.8-Kneutralmateriality 8/10

28-01-2026

MSCI Inc. filed an 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item filing focused on a material event.

Armour Residential REIT, Inc.8-Kneutralmateriality 7/10

28-01-2026

Armour Residential REIT, Inc. filed an 8-K on January 28, 2026, disclosing under Item 1.01 its entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, financial impacts, or strategic rationale are provided. No quantitative metrics, period-over-period comparisons, or other performance data are disclosed.

Apollo Commercial Real Estate Finance, Inc.8-Kneutralmateriality 8/10

28-01-2026

Apollo Commercial Real Estate Finance, Inc. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction size, or financial impacts provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

AEMETIS, INC8-Kneutralmateriality 8/10

28-01-2026

Aemetis, Inc. filed a Form 8-K on 2026-01-28 disclosing entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02, and other events under Item 8.01. This is a multi-item filing with no specific transaction details, personnel names, dollar values, financial impacts, or quantitative metrics provided. No positive or negative performance metrics are mentioned.

Super League Enterprise, Inc.8-Kneutralmateriality 6/10

28-01-2026

Super League Enterprise, Inc. filed a Form 8-K on January 28, 2026, reporting Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the modifications, amendments, or exhibits provided. No financial metrics, positive or negative changes, or quantified impacts are disclosed.

ArrowMark Financial Corp.8-Kneutralmateriality 8/10

28-01-2026

ArrowMark Financial Corp. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, positive or negative changes, or performance comparisons are disclosed in the provided filing summary. This is a multi-item informational filing with no specified sector impacts.

  • Β·AccNo: 0001999371-26-001905
  • Β·File Size: 3 MB
  • Β·Multi-item 8-K filing (Items 1.01, 8.01, 9.01)
Enveric Biosciences, Inc.8-Kneutralmateriality 7/10

28-01-2026

Enveric Biosciences, Inc. filed an 8-K on January 28, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, which may imply dilutive financing but lacks specific details. Item 9.01 includes financial statements and exhibits. No quantitative transaction values, share counts, or financial impacts are disclosed.

Ryman Hospitality Properties, Inc.8-Kneutralmateriality 8/10

28-01-2026

Ryman Hospitality Properties, Inc. filed an 8-K on January 28, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreements, transaction values, financial impacts, or other metrics are provided in the filing summary. This multi-item filing reports material events without quantified positive or negative metrics.

Unknown8-Kneutralmateriality 7/10

28-01-2026

The company filed an 8-K on 2026-01-28 disclosing entry into a Material Definitive Agreement under Item 1.01, with Item 9.01 listing Financial Statements and Exhibits. No specific details regarding the agreement, transaction parties, value, financial impacts, or strategic rationale are provided in the filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

Altimmune, Inc.8-Kneutralmateriality 8/10

28-01-2026

Altimmune, Inc. filed an 8-K on 2026-01-28 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, financial impacts, or strategic rationale are provided. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.

OIL STATES INTERNATIONAL, INC8-Kneutralmateriality 7/10

28-01-2026

OIL STATES INTERNATIONAL, INC filed a Form 8-K on 2026-01-28 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, financial obligation, dollar values, strategic importance, or market impacts disclosed in the provided information. No quantitative metrics, period-over-period comparisons, guidance changes, or scheduled events are mentioned.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 28 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US Corporate Distress Financial Stress SEC Filings β€” January 27, 2026 | Gunpowder Blog